|
ITGB3BP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.086400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.699700E-02 |
| Normal-vs-Stage2 |
1.847630E-02 |
| Normal-vs-Stage3 |
2.132800E-01 |
| Normal-vs-Stage4 |
3.723200E-01 |
| Stage1-vs-Stage2 |
1.468000E-01 |
| Stage1-vs-Stage3 |
6.110000E-01 |
| Stage1-vs-Stage4 |
5.158800E-01 |
| Stage2-vs-Stage3 |
1.197390E-01 |
| Stage2-vs-Stage4 |
1.115190E-01 |
| Stage3-vs-Stage4 |
8.283000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.862390E-01 |
| Normal-vs-AfricanAmerican |
1.623740E-02 |
| Normal-vs-Asian |
8.664100E-03 |
| Caucasian-vs-AfricanAmerican |
3.205900E-02 |
| Caucasian-vs-Asian |
1.910460E-02 |
| AfricanAmerican-vs-Asian |
7.206600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.470200E-01 |
| Normal-vs-Female |
5.243700E-02 |
| Male-vs-Female |
1.247160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.536600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.074000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.938400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.767000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.398820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.258000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.671400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.397200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.944000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.557200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.045400E-01 |
| Classical-VS-Follicular |
9.456100E-03 |
| Classical-VS-Other |
8.990800E-01 |
| Classical-VS-Normal |
3.052400E-01 |
| Tall-VS-Follicular |
3.911400E-01 |
| Tall-VS-Other |
8.498800E-01 |
| Tall-VS-Normal |
2.384000E-01 |
| Follicular-VS-Other |
5.101000E-01 |
| Follicular-VS-Normal |
1.365560E-02 |
| Other-VS-Normal |
6.194000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.110300E-02 |
| Normal-vs-N1 |
7.993400E-01 |
| N0-vs-N1 |
5.816800E-03 |
|
|
